期刊文献+

不同亚型狼疮性肾炎患者临床病理特征和预后的比较 被引量:5

Clinicopathological features and long-term renal outcomes in lupus nephritis patients with different pathological classification
下载PDF
导出
摘要 目的:比较Ⅲ型与Ⅲ+Ⅴ型、Ⅳ型与Ⅳ+Ⅴ型及Ⅳ-S亚型与Ⅳ-G亚型狼疮性肾炎(LN)患者的临床病理特点和肾脏远期预后。方法:收集南京军区南京总医院肾脏科肾脏病登记系统中经肾活检明确诊断为增生型LN、随访时间≥1年的汉族成年患者肾活检时的临床和病理资料。观察终点为终末期肾病(ESRD)。病理分型参照ISN/RPS 2003病理分型方案。结果:Ⅲ型LN患者10年和20年肾脏生存率分别为92.1%和72.2%,Ⅲ+Ⅴ型分别为91.5%和88.9%,Ⅳ型分别为82.7%和60.3%(其中Ⅳ-S亚型分别为86.2%和69.6%;Ⅳ-G亚型分别为81.9%和58.9%),Ⅳ+Ⅴ型分别为82.7%和54.7%。Ⅲ+Ⅴ型和Ⅳ+Ⅴ型LN患者尿蛋白分别重于Ⅲ型和Ⅳ型患者;病理上慢性化病变分别重于Ⅲ型和Ⅳ型患者;急性病变分别轻于Ⅲ型和Ⅳ型患者。Ⅳ-S亚型LN患者抗中性粒细胞胞质抗体阳性率高于Ⅳ-G亚型患者;高血压、蛋白尿、低补体血症轻于Ⅳ-G亚型患者;病理上节段性袢坏死和新月体重于Ⅳ-G亚型患者;白金耳、毛细血管内增生轻于Ⅳ-G亚型患者。结论:Ⅲ型与Ⅲ+Ⅴ型、Ⅳ型与Ⅳ+Ⅴ型、Ⅳ-S亚型与Ⅳ-G亚型LN患者之间虽然临床病理特点不同,但肾脏生存率均无差异。 Objective:To observe the clinicopathological features and renal outcomes between class m and class Ⅲ + V, class IV and class IV + V, and subclass IV-S and IV-G of patients with lupus nephritis. Methodology: The records of all adult patients with biopsy-proven class Ⅲ, class Ⅲ + V, class IV and class IV + V lupus nephritis in the Nanjing Glomerulonephritis Registry followed for at least one year were reviewed. All patients were pathologically classified according to the 2003 International Society of Nephrology/Renal Pathological Society (ISN/RPS) classification system. Results: The levels of proteinuria and histological chronic lesions were severe, while the histological acute lesions were mild in patients with class Ⅲ+ V and IV + V was severe than those in patients with simple class Ⅲ and IV. The rate of serum ANCA was higher, while the degree of hypertension, proteinuria and hypocomplementemia were lower in patients with class IV-S than those in patients with IV-G. The histological lesions of segmental necrosis and crescentic formation were severe, while the lesions of platinum loop and endocapillary proliferation were mild in patients with class IV-S than those in patients with IV-G The 10- and 20-year renal survival rates of LN patients with class Ⅲ were 92. 1% and 72. 2%; with class Ⅲ + V, 91.5% and 88.9%; with class IV, 82. 7% and 60. 3% (with subclass IV-S, 86. 2% and 69. 6%; with subclass IV-G, 81.9% and 58.9%) ; with class IV + V, 82. 7% and 54. 7% ; with 'class V, 96. 8% and 83.8%. Conclusion: Proliferative lesions combined with membranous lesions presented with both clinicopathological characteristics of the two types of lesions, but their renal outcomes were not different from proliferative lesions alone. Subclass IV-S and IV-G had their own characteristics respectively, but the division of class IV into the two subclasses was not meaningful for predicting renal outcomes.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2015年第3期201-206,共6页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 “十二五”国家科技支撑计划课题(狼疮性肾炎及血管炎肾损害的诊断与治疗[2011BAI10B04])
关键词 狼疮性肾炎 肾脏生存率 病理分型 lupus nephritis renal outcome pathological classification
  • 相关文献

参考文献19

  • 1Nossent JC, Bronsveld W,Swaak AJ. Systemic lupus erythematosus. M . Observations on clinical renal involvement and follow up of renal function : Dutch experience with 110 patients studied prospectively. Ann Rheum Dis,1989,48( 10) :810-816.
  • 2Weening JJ,D’Agati VD,Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited.J Am Soc Nephrol,2004,15(2) :241-250.
  • 3Sun HO, Hu WX, Xie HL, et al. Long-term outcome of Chinese patients with membranous lupus nephropathy. Lupus, 2008, 17 ( 1): 56-61.
  • 4Contreras G, Pardo V, Cely C, et al. Factors associated with poor outcomes in patients with lupus nephritis. Lupus, 2005,14 ( 11 ): 890-895.
  • 5Yap DY, Tang CS, Ma MK, et al. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant, 2012,27(8) :3248-3254.
  • 6Mittal B,Hurwitz S,Rennke H, et al. New subcategories of class IV lupus nephritis : are there clinical,histologic,and outcome differences. Am J Kidney Dis,2004,44(6) : 1050-1059.
  • 7Hill GS, Delahousse M, Nochy D, et al. Class IV-S versus class IV-G lupus nephritis : clinical and morphologic differences suggesting different pathogenesis.Kidney Int,2005,68(5) :2288-2297.
  • 8Schwartz MM,Korbet SM,Lewis EJ ; Collaborative Study Group. The prognosis and pathogenesis of severe lupus glomerulonephritis.Nephrol Dial Transplant, 2008,23 (4) : 1298-1306.
  • 9Yu F,Tan Y,Wu LH, et al,Class IV-G and IV-S lupus nephritis in Chinese patients: a large cohort study from a single center. Lupus, 2009,18(12) :1073-1081.
  • 10Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997,40(9) :1725.

同被引文献50

  • 1陈晓明,胡彩凤.浅析八段锦对帕金森病的预防治疗作用[J].三峡大学学报(人文社会科学版),2010,32(S1):193-195. 被引量:7
  • 2Weening JJ, D~gati VD, Schwartz MM, et al. The classification of g|omerulonephritis in systemic lupus erythematosus revisited [J]. J Am Soc Nephrol, 2004,15(2) :241-250.
  • 3Sun HO, Hu WX, Xie HL, et al. Long-term outcome of Chinese patients with membranous lupus nephropathy [ J]. Lupus, 2008, 17(1) :56-61.
  • 4Rovin BH, Parikh SV, Alvarado A. The kidney biopsy in lupus nephritis: is it still relevant? [J]. Rheum Dis Clin North Am, 2014,40 (3) :537-552.
  • 5Giannico G, Fogo AB. Lupus nephritis: is the kidney biopsy cur- rently necessary in the management of lupus nephritis? [ J]. Clin J Am Soc Nephrol, 2013,8( 1 ) :138-145.
  • 6Guedes Marques M, Cotovio P, Ferrer F, et al. Random spot u- rine protein/creatinine ratio: a reliable method for monitoring lu- pus nephritis? [J]. Clin Kidney J, 2013,6(6) : 590-594.
  • 7Mok CC. Biomarkers for lupus nephritis: a critical appraisal [ J]. J Biomed Bioteehnol, 2010,2010:638413.
  • 8Villamin CA, Navarra SV. Clinical manifestations and clinical syndromes of Filipino patients with systemic lupus erythematosus [J]. Mod Rheumatol, 2008,18(2) :161-164.
  • 9Guo Q, Lu X, Miao L, et al. Analysis of clinical manifestations and pathology of lupus nephritis: a retrospective review of 82 cases [ J]. Clin Rheumatol, 2010,29(10) :1175-1180.
  • 10Mavragani CP, Fragoulis GE, Somarakis G, et al. Clinical and la- boratory predictors of distinct histopathogical features of lupus ne- phritis [J]. Medicine ( Baltimore), 2015,94(21 ) :e829.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部